{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Arcturus Therapeutics Holdings Inc."},"Symbol":{"label":"Symbol","value":"ARCT"},"Address":{"label":"Address","value":"10628 SCIENCE CENTER DRIVE,SUITE 250, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 900-2660"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19."},"CompanyUrl":{"label":"Company Url","value":"https://www.arcturusrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Joseph E. Payne","title":"President, Chief Executive Officer & Director"},{"name":"Juergen Kurt Froehlich","title":"Chief Medical Officer"},{"name":"Padmanabh Chivukula","title":"Chief Operating & Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}